"The Covid-19 outbreaks are hitting both the supply and demand for orange juice," Stephen Innes, chief global market strategist at broker AxiCorp said last month. "The immune-boosting properties ...
There's been widespread interest in hydroxychloroquine as both a preventative measure and for treating patients with coronavirus ... led to high demand for the drugs and global supply shortages.